Delivery Order SPE2DB22D3301-SPE2DB24FX4NZ
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,623.02 firm fixed-price delivery order is for the supply of 4560913472 sucralfate 1 gram tablets. The contract has an ultimate completion date of May 12, 2023 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,339.02, is for the delivery of 4,563,250,149 units of Sucralfate 1 GM Tablet 90S, a medication used to treat certain stomach and esophagus problems. This is a firm fixed-price delivery order contract with a period of performance through January 8, 2024. The contract is not designated as a...
- This federal contract award is a Delivery Order worth $2,320.37 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Sucralfate 1 GM Tablets in quantities of 90s. It is an open-competition contract with no set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a wide range...
- This federal contract award, with ID SPE2DB22D2006|SPE2DB24FV9UL, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of sucralfate 1 gram tablets, with a ceiling value of $39,810.57 and a completion date of April 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award, SPE2DB22D3301|SPE2DB25FY3RW, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,782.12 firm fixed-price delivery order is for the supply of 4,568,000 Sucralfate 1 GM Tablet 90S, a medication used to treat peptic ulcers. The contract has an ultimate completion date of April 23, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp...
- This federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The $7,690.03 firm-fixed-price delivery order is for 4,560,895,994 units of Sucralfate 1 GM Tablet 90S. The contract has a period of performance through May 11, 2023 and was awarded on May 10, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,101.89, is for the delivery of 420 ml bottles of 1 gm/10 ml Sucralfate suspension. This is a firm-fixed-price delivery order contract that runs through March 10, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,065.16 fixed-price contract is for the supply of 4,562,853,079 tablets of the medication Sucralfate 1 gram. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award, with ID SPE2DB22D3301|SPE2DB24FX5QX, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,649.58 firm fixed-price delivery order is for the supply of 4562866151 - Sucralfate 1 GM Tablet 90s, with a period of performance ending on November 21, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
- This federal contract award, SPE2DB22D1106|SPE2DB25FDQP9, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,740.44 firm fixed-price delivery order is for the supply of 420 ml of Sucralfate 1 gm/10 ml suspension. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FX4NZDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,215.64 firm fixed-price delivery order contract is for the supply of Sucralfate 1 GM tablets, a medication used to treat certain gastrointestinal conditions. The contract has an ultimate completion date of October 31, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.2k | 10/30/23 |